EUVIMEDEUVIMED entdecken
Crossref

Integrated Multi-omics Reveals CDKN1A Suppression and Metabolic Regulation as Key Mechanisms of Huangqi Guizhi Wuwu Decoction Against Doxorubicin-Induced Cardiotoxicity

Qian Hou, Xinyue Yu, Ke Wu, Siling Chen, Xin Mao, Xinying Qian, Changjin Li, Lidan Sheng, Ruiping Wang, Yin Huang

Cardiovascular Toxicology · 2026

DOI: 10.1007/s12012-026-10168-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2026. Verfasst von Qian Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210029, China. Hauptthemen laut MEDLINE: Doxorubicin, Drugs, Chinese Herbal, Metabolomics, Heart Diseases. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Collaborative Medical Research Project of Traditional Chinese and Western Medicine, National Innovation and Entrepreneurship Training Program for Undergraduate.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical utility of doxorubicin (DOX) is severely limited by dose-dependent cardiotoxicity, for which effective interventions remain scarce. Huangqi Guizhi Wuwu Decoction (HGWD) shows promising cardioprotective potential, but its mechanisms against DOX-induced cardiotoxicity (DIC) remain unexplored. This study explored the molecular mechanisms using an integrated metabolomics and transcriptomics approach. We identified 57 compounds in HGWD by liquid chromatography ion trap time-of-flight mass spectrometry (LC-IT-TOF/MS), and quantified five representative compounds for standardization. Mice were randomized into six groups: control, DOX (10 mg/kg × 2), DOX + low-dose HGWD (7 g/kg/d), DOX + high-dose HGWD (14 g/kg/d), DOX + dexrazoxane (100 mg/kg × 2), and HGWD (14 g/kg/d) alone. HGWD effectively alleviated cardiac dysfunction and reduced serum injury markers, with the high-dose group demonstrating efficacy comparable to the positive control drug, dexrazoxane. Subsequently, multi-omics profiling was performed on heart tissues from the control, DOX, and DOX + high-dose HGWD groups. Metabolomics identified 31 differential metabolites, highlighting energy metabolism restoration (e.g., acylcarnitines, citric acid) and inflammatory mediator modulation (e.g., arachidonic acid). Transcriptomics uncovered 37 genes enriched in innate immunity (e.g., Irf7, Isg15) and apoptosis (e.g., Bax, Cdkn1a). Network analysis constructed a core regulatory module, pinpointing CDKN1A as a potential mediator. Validation experiments confirmed that HGWD suppressed DOX-induced CDKN1A upregulation in mouse hearts. Furthermore, in H9c2 cells, HGWD mitigated DOX-induced apoptosis and inflammation, exhibiting cytoprotection comparable to pifithrin-α, a specific p53 inhibitor. In summary, HGWD protects against DIC by modulating a multi-target network and the suppression of CDKN1A represents a key underlying mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDrugs, Chinese HerbalMetabolomicsHeart DiseasesMyocytes, CardiacCyclin-Dependent Kinase Inhibitor p21Energy MetabolismTranscriptomeAnimalsCardiotoxicityMaleDisease Models, AnimalMultiomicsMice, Inbred C57BLSignal TransductionApoptosisMice

Stichwörter der Autor:innen

CardiotoxicityHuangqi Guizhi Wuwu DecoctionMulti-omicsNetwork modulep21

Substanzen

DoxorubicinDrugs, Chinese HerbalCyclin-Dependent Kinase Inhibitor p21Cdkn1a protein, mousehuangqi decoction

Autor:innen und Institutionen

  • The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210029, China.
  • Department of Traditional Chinese Internal Medicine, Zhongda Hospital, Southern University, Nanjing, 210009, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China.
  • School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • CSPC Zhongqi Pharmceutical Technology Co (Shijiazhuang)., Ltd, Shijiazhuang, 050035, China.
  • The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210029, China. yfy137@njucm.edu.cn.

Förderung

  • Collaborative Medical Research Project of Traditional Chinese and Western Medicine
  • National Innovation and Entrepreneurship Training Program for Undergraduate

Zitieren

APA

Hou, Q., Yu, X., Wu, K., Chen, S., Mao, X., Qian, X., Li, C., Sheng, L., Wang, R., & Huang, Y. (2026). Integrated Multi-omics Reveals CDKN1A Suppression and Metabolic Regulation as Key Mechanisms of Huangqi Guizhi Wuwu Decoction Against Doxorubicin-Induced Cardiotoxicity. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-026-10168-x

Vancouver

Hou Q, Yu X, Wu K, Chen S, Mao X, Qian X, et al. Integrated Multi-omics Reveals CDKN1A Suppression and Metabolic Regulation as Key Mechanisms of Huangqi Guizhi Wuwu Decoction Against Doxorubicin-Induced Cardiotoxicity. Cardiovascular Toxicology. 2026. doi:10.1007/s12012-026-10168-x

BibTeX
@article{Hou2026,
  author = {Hou, Qian and Yu, Xinyue and Wu, Ke and Chen, Siling and Mao, Xin and Qian, Xinying and Li, Changjin and Sheng, Lidan and Wang, Ruiping and Huang, Yin},
  title = {Integrated Multi-omics Reveals CDKN1A Suppression and Metabolic Regulation as Key Mechanisms of Huangqi Guizhi Wuwu Decoction Against Doxorubicin-Induced Cardiotoxicity},
  journal = {Cardiovascular Toxicology},
  year = {2026},
  doi = {10.1007/s12012-026-10168-x}
}
Kostenlos starten →